NCT02523859View on ClinicalTrials.gov

Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery

PHASE3TerminatedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Anesthesia

Interventions

DRUG

Propofol

Hypnotic drug used for anesthesia

DRUG

Remimazolam

Benzodiazepine being developed for sedation and anesthesia.

Trial Locations (1)

04289

Herzzentrum Leipzig GmbH, Leipzig

Sponsors

Collaborators (1)

PRA Health Sciences

All Listed Sponsors

collaborator

PRA Health Sciences

INDUSTRY

lead

Paion UK Ltd.

INDUSTRY

NCT02523859 - Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter